文献速递疝与腹壁外科围术期管理与 ERAS

生物补片加固的原发筋膜闭合在腹壁重建中并发症与复发率低于桥接修补:倾向评分分析

Primary fascial closure with biologic mesh reinforcement results in lesser complication and recurrence rates than bridged biologic mesh repair for abdominal wall reconstruction: A propensity score analysis.
PubMed 文献 · Surgery · 2016-10-31

该回顾性研究纳入535例在癌症中心接受腹壁重建的患者,其中484例(90%)行补片加固修补、51例(10%)行桥接修补,脱细胞真皮基质使用率分别为96%和98%。倾向评分匹配分析(n=100)显示桥接修补的疝复发率(32% vs 6%,P=.002)、总体并发症率(32% vs 6%,P=.002)均更高,无疝复发率更差(68% vs 32%,P=.001)。结论认为腹壁重建应尽可能采用加固修补而非桥接修补。

要点

  • 桥接修补疝复发率33.3% vs 加固修补6.2%(P<.001)。
  • 桥接修补总体并发症率59% vs 加固修补30%(P=.001)。
  • 桥接修补伤口裂开率26% vs 14%(P=.034)、补片暴露率10% vs 1%(P=.003)。

核心结论

  • 在主要为癌症患者的群体中,桥接修补腹壁重建的结局劣于补片加固修补。
  • 尤其在使用脱细胞真皮基质时,腹壁重建应尽可能采用加固修补。

研究设计与样本

  • 回顾性研究,纳入535例因切口疝或恶性肿瘤切除后腹壁缺损接受腹壁重建的患者。
  • 484例(90%)行补片加固修补,51例(10%)行桥接修补;桥接与加固修补中脱细胞真皮基质使用率分别为98%和96%。
  • 采用倾向评分分析进行多变量风险调整及1:1匹配(匹配对数n=100)。

主要发现

  • 桥接修补疝复发率高于加固修补(33.3% vs 6.2%,P<.001)。
  • 桥接修补总体并发症率高于加固修补(59% vs 30%,P=.001),无疝复发率更差(log-rank P<.001)。
  • 桥接修补伤口裂开率(26% vs 14%,P=.034)和补片暴露率(10% vs 1%,P=.003)均高于加固修补。
  • 倾向评分匹配后(n=100),桥接修补的疝复发率(32% vs 6%,P=.002)、总体并发症率(32% vs 6%,P=.002)更高,无疝复发率更差(68% vs 32%,P=.001)。
  • 两组在伤口愈合和补片并发症方面未观察到差异。

临床怎么用

  • 腹壁重建时应优先选择补片加固的原发筋膜闭合,而非桥接修补。
  • 使用脱细胞真皮基质时更应避免桥接修补,以降低疝复发和并发症风险。

局限性

  • 回顾性研究设计,存在选择偏倚可能。
  • 样本以癌症患者为主,外推至普通人群需谨慎。
  • 桥接修补组样本量较小(51例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies suggest that bridged mesh repair for abdominal wall reconstruction may result in worse outcomes than mesh-reinforced, primary fascial closure, particularly when acellular dermal matrix is used. We compared our outcomes of bridged versus reinforced repair using ADM in abdominal wall reconstruction procedures. METHODS: This retrospective study included 535 consecutive patients at our cancer center who underwent abdominal wall reconstruction either for an incisional hernia or for abdominal wall defects left after excision of malignancies involving the abdominal wall with underlay mesh. A total of 484 (90%) patients underwent mesh-reinforced abdominal wall reconstruction and 51 (10%) underwent bridged repair abdominal wall reconstruction. Acellular dermal matrix was used, respectively, in 98% of bridged and 96% of reinforced repairs. We compared outcomes between these 2 groups using propensity score analysis for risk-adjustment in multivariate analysis and for 1-to-1 matching. RESULTS: Bridged repairs had a greater hernia recurrence rate (33.3% vs 6.2%, P < .001), a greater overall complication rate (59% vs 30%, P = .001), and worse freedom from hernia recurrence (log-rank P <.001) than reinforced repairs. Bridged repairs also had a greater rate of wound dehiscence (26% vs 14%, P = .034) and mesh exposure (10% vs 1%, P = .003) than mesh-reinforced abdominal wall reconstruction. When the treatment method was adjusted for propensity score in the propensity-score-matched pairs (n = 100), we found that the rates of hernia recurrence (32% vs 6%, P = .002), overall complications (32% vs 6%, P = .002), and freedom from hernia recurrence (68% vs 32%, P = .001) rates were worse after bridged repair. We did not observe differences in wound healing and mesh complications between the 2 groups. CONCLUSION: In our population of primarily cancer patients at MD Anderson Cancer Center bridged repair for abdominal wall reconstruction is associated with worse outcomes than mesh-reinforced abdominal wall reconstruction. Particularly when employing acellular dermal matrix, reinforced repairs should be used for abdominal wall reconstruction whenever possible.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Giordano S, Garvey PB, Baumann DP, et al. Primary fascial closure with biologic mesh reinforcement results in lesser complication and recurrence rates than bridged biologic mesh repair for abdominal wall reconstruction: A propensity score analysis. Surgery. 2016. PMID: 27810091. doi:10.1016/j.surg.2016.08.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。